Drug discontinuation: Tobramycin Sulfate Injection (TOBRAMYCIN)
FDA lists 1 presentation as To Be Discontinued. Companies: Hospira, Inc., a Pfizer Company.
- Published by source
- 2026-07-17
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Tobramycin Sulfate Injection TOBRAMYCIN
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-07-17
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #1038 | new | 2026-10-22 | 6f04c5592390…5d180d | 816dd9d51718…87fe84 |
Chain head: #1076 8ad5adc30b9b…88ce20